Xtant Medical Announces Acquisition Of nanOss Production Operations From RTI Surgical; The Purchase Price For The Assets Was $2 Million In Cash Plus Contingent Payments Based On Future Sales Of Next Generation NanOss Products
Portfolio Pulse from Happy Mohamed
Xtant Medical Holdings, Inc. (NYSE:XTNT) has acquired the nanOss production operations from RTI Surgical, Inc. The purchase includes certain assets, equipment, inventory, and the lease for the nanOss production facility. The deal was worth $2 million in cash plus contingent payments based on future sales of next generation nanOss products. This acquisition expands Xtant's manufacturing capabilities and capacity, and is expected to drive growth.
October 23, 2023 | 8:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Xtant Medical's acquisition of nanOss production operations from RTI Surgical expands its manufacturing capabilities and capacity. The deal, worth $2 million plus future sales-based payments, is expected to drive growth for Xtant.
The acquisition of nanOss production operations from RTI Surgical is a strategic move for Xtant Medical. It not only expands their manufacturing capabilities and capacity but also positions them to improve their cash flows. This is likely to have a positive impact on the company's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100